Sign In
Buy QGEN
$41.40
-0.0500 (-0.121%)
At Close: Jul 31, 2026
Qiagen, Inovio In Development Pact For VGX-3100 Companion Diagnostics
07:26am, Wednesday, 24'th Feb 2021
Qiagen NV (NYSE: QGEN) and Inovio Pharmaceuticals Inc (NASDAQ: INO) expanded their partnership with a new master collaboration agreement to develop liquid biopsy-based companion diagnostic prod
PLYMOUTH MEETING, Pa. & GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN and INOVIO expand collaboration to develop next generation sequencing (NGS) companion diagnostic for INOVIO
QIAGEN Expands Supervisory Board With Appointment of a New Member
04:08pm, Monday, 22'nd Feb 2021
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN expands Supervisory Board with appointment of a new member
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q4 2020 Results - Earnings Call Transcript
03:10pm, Wednesday, 10'th Feb 2021
QIAGEN N.V. (QGEN) CEO Thierry Bernard on Q4 2020 Results - Earnings Call Transcript
QIAGEN (QGEN) Q4 Earnings Beat Estimates, Margins Improve
10:56am, Wednesday, 10'th Feb 2021
QIAGEN's (QGEN) high level of sales for product groups used in the COVID-19 pandemic response drove the top line.
Qiagen (QGEN) Beats Q4 Earnings and Revenue Estimates
06:57pm, Tuesday, 09'th Feb 2021
Qiagen (QGEN) delivered earnings and revenue surprises of 3.03% and 3.51%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Qiagen Q4 Earnings
05:48pm, Tuesday, 09'th Feb 2021
Shares of Qiagen (NYSE:QGEN) moved higher in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 41.67% year over year to $0.68, which beat the e
QIAGEN (QGEN) Announces COVID-19 Test Updates as Cases Rise
10:32am, Tuesday, 26'th Jan 2021
QIAGEN (QGEN) along with with Australia-based digital diagnostics company, Ellume develops QIAreach SARS-CoV-2 Antigen Test.
QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results
07:10am, Tuesday, 26'th Jan 2021
VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. to Report Fourth Quarter and Full-Year 2020 Results
QIAGEN Plans to Resubmit EUA Submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the First Quarter of 2021
04:08pm, Wednesday, 20'th Jan 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN plans to resubmit EUA submission in the U.S. for QIAreach SARS-CoV-2 Antigen Test in the first quarter of 2021
QIAGEN Confirms Effectiveness of Its SARS-CoV-2 PCR Tests in the Face of Mutations of the Coronavirus
04:05pm, Wednesday, 20'th Jan 2021
GERMANTOWN, Md. & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN--QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus
Testing Space in Focus Again Thanks to New Wave of Coronavirus
10:32am, Wednesday, 13'th Jan 2021
The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.
QIAGEN Announces Appointment of New Supervisory Board Member
07:00am, Friday, 08'th Jan 2021
VENLO, The Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN announces appointment of new Supervisory Board member
3 Soaring MedTech Stocks That Might Lose Ground in 2021
09:47am, Wednesday, 30'th Dec 2020
Despite MedTech industry's bright prospects in 2021, investors should be wary of stocks like BLFS, STAA and TGTX, given their unfavorable Zacks Rank and weak fundamentals.
QIAGEN Underlines and Innovates Its Commitment to Sustainability With a EUR 400mn Sustainability-linked Credit Facility
04:05pm, Thursday, 17'th Dec 2020
VENLO, Netherlands--(BUSINESS WIRE)---- $QGEN--QIAGEN underlines and innovates its commitment to sustainability with a EUR 400mn sustainability-linked credit facility
